Low maternal vitamin D as a risk factor for schizophrenia: A pilot study using banked sera

John McGrath, Darryl Eyles, Bryan Mowry, Robert Yolken, Stephen Buka

Research output: Contribution to journalArticlepeer-review


Objective: Evidence from epidemiology suggests that low maternal vitamin D may be a risk factor for schizophrenia. Method: Based on sera taken during the third trimester, we compared the level of 25 hydroxyvitamin D3 in mothers of individuals with schizophrenia or schizoaffective disorders versus mothers of unaffected controls. For each case, we selected two controls matched on race, gender and date of birth of the offspring. Results: There was no significant difference in third trimester maternal vitamin D in the entire sample (cases=26, controls=51). Within the subgroup of black individuals (n=21), there was a trend level difference in the predicted direction. Conclusions: Maternal vitamin D does not operate as a continuous graded risk factor for schizophrenia, however, the results in the black subgroup raise the possibility that below a certain critical threshold, low levels of maternal vitamin D may be associated with an increased risk of schizophrenia.

Original languageEnglish (US)
Pages (from-to)73-78
Number of pages6
JournalSchizophrenia Research
Issue number1-2
StatePublished - Sep 1 2003


  • Banked sera
  • Schizophrenia
  • Vitamin D

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry


Dive into the research topics of 'Low maternal vitamin D as a risk factor for schizophrenia: A pilot study using banked sera'. Together they form a unique fingerprint.

Cite this